BacterOMIC takes antibiotic susceptibility testing (AST) to the next level
by offering quantitative evaluation of all clinically relevant antibiotics
and identificaton of synergistic pairs of antibiotics
The system uses the most trusted microdilution AST, combined with cutting-edge microfluidics to provide unprecedented information density on a single disposable panel. Our technology delivers the first fully comprehensive test – a single panel contains up to 80 clinically relevant antibiotics, or up to 20 checkerboard combinations of antibiotics. For each antibiotic BacterOMIC provides a true MIC value.
Technology
Bacteromic uses the combination of cutting edge microfluidics, detection, data analysis and automation to offer unprecedented information content, throughput, ease of use with virtually no barier to adoption
Microfluidics
- Properietary network of incubation microchambers
- All-in-one cap and sealing technology
- Best-in-class ease of use
Detection & Data Analysis
- Two methods of detecting bacterial growth
- Custom signal and data analysis solutions
- Real-time reporting for MIC and FIC results in the shortest time possible
Fully Automated Testing
- Analysis of up to 60 cartridges
- Random access
- Simplified manual workflow
640 isolated microchambers, each containing
a different antibiotic environment
Analysis of up to 60 panels in parallel,
with random access
Patents pending:
EP 18189593.9
WO 2019/185885 A1
PL 425107
Recorded signal from incubation chamber
and classification of recorded growth curves
Patents pending:
EP 3597768 A1
WO 2020/016200 Α1
Patents pending:
EP 18189586.3
WO 2019/185927 A1
PL 425106
BacterOMIC signal analysis
During incubation, signals from each chamber are classified as positive or negative using PCA analysis
Sample loading
Incubation
Signal detection
Classification of growth curves
Real time reporting
of results
Advantages
the first automated system that tests all clinically relevant antibiotics in a single test
the first system to test multiple antibiotic combinations to identify synergies effective against AMR
compliance with EUCAST and CLSI guidelines
same workflow and pricing as existing products
BacterOMIC brings value to all shareholders in the AMR challenge:
- Laboratories
- Hospitals
- Patients
Minimum barriers to adoption
Fully compatible with traditional workflow in central and hospital labs
Isolated bacterial strain
Monocultural bacterial suspension
Transfer of suspension into the cartridge
Closing a cap
Placing the cartridges
in a rack
Placing the cartridges rack in automated filling device
Filling up to 10 cartridges at a time
Transfer of filled cartridges into the analyzer
Fully automated analysis of up to 60 samples
Best in class ease of use, compatible with standard microbiology workflows
Competitive pricing
Intuitive software with real-time reporting
Panels
Universal panel
- up to 80 antibiotics
- true MIC for every antibiotic
- automatic susceptibility classification
Synergy panel
- up to 20 combinations
- FIC for every combination
- automatic combined effect classification